Physician profile
Rhonda Crouch
NPI 1164546636
$917.41
in general payments reported to CMS, 2019-2025
12 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $154 · 2022: $33.83 · 2023: $66.82 · 2024: $339 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $250.00 | 2021-2025 | |
| Smith+Nephew, INC. | $178.92 | 2023-2024 | Stravix, Oasis, Grafix |
| Solventum Corporation | $140.12 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Melinta Therapeutics, LLC | $116.07 | 2024 | Kimyrsa |
| Bioventus LLC | $48.15 | 2021-2022 | |
| Abbvie INC. | $47.12 | 2021-2025 | |
| Acera Surgical, INC. | $43.89 | 2025 | Restrata Wound Matrix |
| Paratek Pharmaceuticals, INC. | $21.09 | 2023 | Nuzyra |
| Ferring Pharmaceuticals INC. | $19.03 | 2025 | Euflexxa |
| Novartis Pharmaceuticals Corporation | $18.31 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $17.90 | 2025 | |
| Kci USA, INC. | $16.81 | 2023 | Prevena, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhonda Crouch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.